HR Performance Solutions is a growing software-as-a-service company focused on HR technology. The primary areas of focus include 1) performance management, 2) salary administration, and 3) learning management.
ETB is a sports nutrition-based lifestyle business, providing clean and lean supplements to support pure achievement. We seek to engender a sense of mental and physical well-being to encourage and enable individuals to overcome obstacles and push through life’s challenges
The biggest unmet medical need is to provide safe and efficacious drugs to the patient. However, the pharmaceutical industry is currently facing a litany of challenges, including but not limited to: 1) lead identification; 2) lead optimization & prioritization; 3) predicting side effects and toxicity; 4) meeting efficacy requirements; 5) maximizing patent life on the market; and 6) product rescue/repositioning. As a result, R&D success rates are falling, and R&D spending is not contributing to increased sales. According to research by Jack Scannell published in Nature, “...the number of new…
Vystar Corporation holds four domestic US patents and multiple global patents to remove the antigenic proteins from natural rubber latex. Vytex is the brand name and is used in adhesives, balloons, condoms, gloves, foam, etc. The most prevalent is our recent foray into the domestic mattress, toppers and pillow markets.
Auritec Pharmaceuticals, Inc. is a research and development (R&D) company, specializing in innovative, extended release drug delivery systems. Auritec was founded by Thomas J. Smith, MD. Dr. Smith was previously Medical Director and Chairman at Control Delivery Systems, Inc. (CDS), where he was the co-founder and PI on key patents. CDS, now Psivida Inc. (NASDQ - PSDV), is a successful device company specializing in ophthalmic extended release therapies. Dr. Smith is joined on Auritec's management team by Gary Ransom, a seasoned international business executive, who focuses on strategy,…
QUADRAS is a global provider of unique, enterprise-class Data Collection and Professional Service solutions, with a specialization in mobile data capture and RFID technologies. Our business solutions are focused on optimizing operations, reducing expenses, and improving business processes, and they have successfully been applied across a wide range of industries.As recognized leaders in the Data Collection, RFID, and EAM/IT Consulting fields, we stand behind our know-how, our recommendations, and our implementations - we will execute what we promise and help you attain your key performance…
Zeteo’s focus is on advanced technology development for customers in the national security sector and life science markets. Zeteo's customers include DoD, DHS and the Bill and Melinda Gates Foundation. Our core technology focus areas are: 1. Life science and biosecurity diagnostics2. Advanced imaging systems3. Decontamination and disinfection technology
ProNAi Therapeutics is a drug development company advancing targeted therapeutics for the treatment of patients with cancer. We are an ambitious oncology drug development company oriented towards registration and commercialization. We have a world-class management team with a proven track record of success in oncology drug development and we intend to build a broad and diverse pipeline of promising oncology assets against emerging targets on the leading edge of cancer biology.
Arazy Group Consultants Inc. is a global regulatory affairs firm providing technology services and products designed to streamline, simplify, and expedite international regulatory affairs for all types of medical and IVD devices. Arazy Group is the company behind GRIMS™ an innovative, platform to streamline and simplify the regulatory approval process across multiple countries, which is currently fragmented, costly and inefficient. In 2015 Arazy Group was honored with the prestigious Innovator of the Year and excellence in Cloud Computing Awards by Frost & Sullivan. The awards goes to…
Green Gorilla is an international group focused on expanding our world's access to hemp based solutions. We believe that hemp holds incredible promise as a renewable source of medicines, foods, fuel, textiles, plastics, building materials, pulp & paper, and much more. The proper cultivation of hemp and extraction of its many wonderful components will be a positive force to help heal our bodies and preserve our environment. At Green Gorilla we are committed to unlocking this potential, and to making sustainable and ethical choices to protect our planet and our future.
Amarantus BioScience Holdings, Inc. is a publicly traded biotechnology company focused on developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology.Amarantus is active in exploring a number of strategic options for Amarantus Diagnostics, including a potential spin off, to derive the full value of its premier neurodiagnostics business.
INTERVENT International, LLC (INTERVENT) is a global lifestyle management and chronic disease risk reduction company based in the United States. INTERVENT develops, licenses and provides evidence-based, technology-enabled, outcomes-oriented programs for the prevention and management of multiple chronic diseases. The primary purpose of the INTERVENT programs is to improve individual and population-based measures of health while simultaneously reducing health care costs and enhancing productivity. The programs provide unique solutions for employers, health insurers, health care systems,…
Alpha Cancer Technologies Inc., (ACT) is a private clinical stage biotechnology company with products under development in oncology and auto-immune disease indications. The company’s drug products use our proprietary recombinant human alpha fetoprotein (AFP) with unique immuno-oncology properties.One of the largest US biotech companies recently purchased a 14% equity stake in ACT for US $7.5 million as part of a larger financing with institutional and private investors.
Barnes Healthcare Services was founded in 1909 by Charles W. Barnes, Rph. in a corner drug store in Valdosta, Georgia. In those days medications were compounded by hand and the horse was the main mode of transportation. In 1946 Barnes supplied its first patient with a hospital bed, oxygen and a wheelchair. The business has been passed down through three generations to Charles W. Barnes, III whose vision, dedication to the patient, and desire to be the best provider in the area has grown the business to 21 locations in Georgia, Florida, and Alabama.
ZS Genetics, Inc. engages in the research, development, and commercialization of a single-molecule technology for DNA sequencing. The company develops electron microscopy-based DNA sequencing technology, which is used to read DNS sequences directly from digital images of DNA itself. Its technology is used in various applications in genomics research and diagnostic markets. The company was founded in 2003 and is based in Wakefield, Massachusetts.
Alba Biologics Group is a leading biopharmaceutical strategic and technical support group providing consulting and management services to start-ups, early product developers and established industry leaders. With 20 years experience Alba Biologics leverages the expertise of the founder and our associates to help clients advance drug candidates from the bench through to regulatory approval. Alba will support client organizations on both short and long term projects working with a clientпїЅs in house staff as well as integrating with contract service providers.Alba Biologics brings to the…
MediNatura is dedicated to manufacturing and distributing high quality, FDA regulated products. We know people can improve their lives by making healthy lifestyle choices, healthy food choices and healthy medicine choices. MediNatura's mission is to improve lives with medicines from nature.
Creabilis is a clinical-stage, specialty pharmaceutical company focusing on the development of innovative, first-in-class topical treatments in the field of dermatology. The Company’s lead product, CT327, is a Phase III-ready topical treatment for chronic pruritus (itch), which the Company believes is the most advanced, novel, topical treatment in development for the indication. Pruritus is a debilitating symptom of many dermatological diseases, with a significant negative impact on a patient’s quality of life.
